ReviewLife (Basel, Switzerland)2023

Tocilizumab for Severe COVID-19 Infection and Multisystem Inflammatory Syndrome in Adults and Children.

Amber N Edinoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.